Australia markets closed

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9000-0.0300 (-1.55%)
As of 09:38AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.9300
Open1.8900
Bid1.8200 x 1400
Ask1.9200 x 1200
Day's range1.8900 - 1.9000
52-week range0.3500 - 5.2000
Volume25,305
Avg. volume6,623,124
Market cap59.806M
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-2.5480
Earnings date10 Nov 2022 - 14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date20 Aug 2015
1y target est16.00
  • GlobeNewswire

    Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results

    SOUTH SAN FRANCISCO, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its operating and financial results for the second quarter ended June 30, 2022. “We were very pleased to have completed the sale of our complement portfolio during the second quarter to Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) (“Vertex”) for $60.0 million in cash with up to $5.0 million of that amount due in May 2023. This transaction was the

  • Business Wire

    JDS1, LLC Terminates Proxy Contest at Catalyst’s 2022 Annual Meeting

    FORT LEE, N.J., August 11, 2022--JDS1, LLC ("JDS1"), which collectively with the other reporting persons in its Section 13(d) group, beneficially owns approximately 8.4% of the outstanding common stock of Catalyst Biosciences, Inc. (NASDAQ: CBIO) ("Catalyst" or the "Company"), commented today on its previously announced withdrawal of the director nominations and other proposed business that it had intended to bring before the upcoming 2022 Annual Meeting of Stockholders of Catalyst Biosciences,

  • GlobeNewswire

    Catalyst Biosciences Announces Withdrawal of JDS1 Nominations to the Board

    Encourages Stockholders to Vote on the WHITE Proxy CardSOUTH SAN FRANCISCO, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company,” “Catalyst” or “we”) announced that it has received a notice from JDS1, LLC (“JDS1”) that JDS1 has withdrawn the nominations of Shelly C. Lombard, Matthew Stecker, and Igor Volshteyn (the “Withdrawn Candidates”) for election to the Catalyst Board of Directors at the Catalyst 2022 annual meeting of stockholders (the “2022 An